ustekinumab
ustekinumab noun: a human monoclonal antibody directed against interleukin 12 and interleukin 23, in clinical trials for multiple sclerosis, psoriasis, and psoriatic arthritis.
Noun
ustekinumab (uncountable)
- A human monoclonal antibody directed against interleukin 12 and interleukin 23, in clinical trials for multiple sclerosis, psoriasis, and psoriatic arthritis.
- As another interleukin 12/23 antagonist, briakinumab, was withdrawn from further development in part due to concerns about cardiovascular safety, discussion has also emerged on cardiovascular safety of ustekinumab.2015 December 4, “Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients”, in PLOS ONE, →DOI
Origin of ustekinumab
From -kin- (“interleukin”) + -umab (“human monoclonal antibody”).
Words formed from ustekinumab
Questions about ustekinumab
- What does ustekinumab mean?
- Ustekinumab means a human monoclonal antibody directed against interleukin 12 and interleukin 23, in clinical trials for multiple sclerosis, psoriasis, and psoriatic arthritis.
- What part of speech is ustekinumab?
- Ustekinumab is a noun.
Words near ustekinumab in the dictionary
Source and license
Adapted from Wiktionary: ustekinumab (page history and authors). Text available under the Creative Commons Attribution-ShareAlike 4.0 license. Word.ws reformatted the entry and added links. Wiktionary data of 2026-09-02.
Last updated:
Cite this entry: “ustekinumab.” Word.ws, https://word.ws/ustekinumab. Based on Wiktionary, CC BY-SA 4.0.
